Ftse Mib
34.191,79
-0,48%
DAX
19.210,81
-0,17%
S&P 500
5.870,62
-1,32%
NASDAQ
18.680,12
-2,24%
Bitcoin
90.565,22
-0,54%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ PMV Pharmaceuticals Inc (PMVP) PMV Pharmaceuticals Inc (PMVP) Notizie

PMV Pharmaceuticals Inc

PMVP
1,61
0,01 (0,63%)
16 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
07/11/202414:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202414:00EDGAR2Form 8-K - Current report
07/11/202414:00GLOBEPMV Pharmaceuticals Reports Third Quarter 2024 Financial..
23/10/202414:00GLOBEPMV Pharmaceuticals Provides a Progress Update on PYNNACLE..
03/10/202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202422:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202423:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202422:02EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
08/8/202414:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202414:00EDGAR2Form 8-K - Current report
08/8/202414:00GLOBEPMV Pharmaceuticals Reports Second Quarter 2024 Financial..
16/7/202415:02EDGAR2Form SC TO-I - Tender offer statement by Issuer
10/6/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202414:32EDGAR2Form 8-K - Current report
30/5/202413:00GLOBEPMV Pharmaceuticals to Participate at Upcoming Investor..
29/5/202413:00BWFoundation Medicine and PMV Pharma Announce Collaboration to..
09/5/202414:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202414:00EDGAR2Form 8-K - Current report
09/5/202414:00GLOBEPMV Pharmaceuticals Reports First Quarter 2024 Financial..
27/3/202413:00GLOBEPMV Pharmaceuticals Announces First Patient Dosed in Global..
18/3/202421:01GLOBEPMV Pharmaceuticals PYNNACLE Phase I Data of Rezatapopt in..
29/2/202422:05EDGAR2Form 8-K - Current report
29/2/202422:01GLOBEPMV Pharmaceuticals Reports Full Year 2023 Financial Results..
26/2/202414:00GLOBEPMV Pharmaceuticals to Participate in the TD Cowen 44th..
24/1/202415:01EDGAR2Form S-8 - Securities to be offered to employees in employee..
22/1/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202422:02EDGAR2Form 8-K - Current report
18/1/202422:01GLOBEPMV Pharmaceuticals Announces Prioritization of PC14586..
11/1/202422:18EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/1/202422:01EDGAR2Form 8-K - Current report
05/1/202422:01GLOBEPMV Pharmaceuticals Strengthens Leadership with Key..
Apertura: 1,61 Min: 1,595 Max: 1,7465
Chiusura: 1,60

La tua Cronologia

NASDAQ
PMVP
PMV Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network